Khiron Muscles Up on Hookup with German Firm

Khiron Muscles Up on Hookup with German Firm

By: Tomas Ronolski - News

Thursday, June 25, 2020

More developments from the cannabis front Thursday. Toronto-based Khiron Life Sciences Corp. (TSX-Venture: KHRN), a vertically integrated cannabis leader with core operations in Latin America and Europe, joined in an agreement with Nimbus Health, a leading German distributor of medical cannabis products.  Khiron branded EU GMP medical cannabis will soon be available in Germany for prescription by doctors and dispensation in pharmacies.

Tejinder Virk, President of Khiron Europe, commented: "This is a major milestone for our company. Following our recent entry into the United Kingdom, the expansion into Germany will greatly benefit patients who still suffer from inconsistent supply.  Khiron is now well positioned to service this rapidly expanding market in Germany."

KHRN shares did not have the jump some stocks in this category sometimes enjoy, only two cents, or 3.7%, to 56 cents, though volume was a respectable 552,000 shares.

Copyright © 2020 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

A Treasure Trove of Uranium Being Sought by Junior Explorer
PowerBand Makes Waves
Therapix Stands out Among Losing Health-Care Sectors
Most Popular
FREE Newsletter

Back to Top